Testimonial coming soon...
Product/Service: REPROCELL was established with the goal of contributing to people’s health and welfare through the development of stem cell technologies.
Deal Cycle: 3 – 6 months
Location: USA & Europe
Company Size: Any, but initial focus on larger
Role/Function: Owners & C-suite, or senior figures in R&D, projects and a range of specific scientific areas
- Offer Research Contracts to Pharma companies who would like to test IBD drugs in Reprocell labs. Contract Research Service Offering under the BIOPTA brand
- REPROCELL’s stem cell services team is a specialized research group with training in stem cell biology received in leading stem cell labs from around the world
- They will provide exactly the cells needed for investigations, freeing up time and resources to focus on the research
- Focus is to start dialogue with ideally large Pharma companies in the US and EU, initially inviting them for a call around the two core offerings: IBD and Stem Cell IPC